|
|
|
Click here for
Registration Form or Brochure
Home
Study Course Information and Frequently Asked Questions
|
|
Multi-Theme Courses
Each volume contains valuable lessons on a variety of topics important to
your practice. Three interesting volumes are available from which
to choose.
Please pay special attention to expiration dates.
|
|
Volume 34 (16 CE hrs)
Price - $60 per volume
Must submit for CE credit by 03/15/2011
Lesson 1. Pharmacist-Delivered Tobacco Cessation
4 contact hours, 018-999-08-701-H01
Author: Larry A. Dent, Pharm.D., BCPS, University of Montana Skaggs
School of Pharmacy
Educational Goals: (i) describe
prevalence and epidemiology of tobacco use and discuss health risks,
environmental effects, economic burden. (ii) explain the benefits of
smoking cessation, list components of nicotine addiction. (iii) apply
tobacco cessation strategies, counsel in pharmacotherapy. (iv)
recognize benefits, appropriate use, side effects, duration, monitor
drug therapies, identify components of cognitive and behavioral change
counseling.
Lesson 2. Patient Centered Care: Pharmacist Adult Vaccination
4 contact hours, 018-999-08-702-H01
Authors: Beverly A. Sullivan, Pharm.D. & Kerri Kilgore, Pharm.D.,
University of Wyoming School of Pharmacy
Educational Goals: (i) identify
current recommended adult vaccines, storage, overall safety and
management of adverse effects. (ii)
recognize and describe the proper administration of vaccinations
in adults. (iii) describe
process to screen adults seeking vaccination and to document
administration. (iv) identify
pharmacist liability in provision of adult vaccinations.
Lesson 3. Principles of Obesity Management and Weight Control
4 contact hours, 018-999-08-703-H01
Authors: Judy T. Chen, Pharm.D., BCPS, & Amy Heck Sheehan,
Pharm.D., Purdue University School
of Pharmacy; Devra K. Dang, Pharm.D., University of Connecticut School
of Pharmacy;
Educational Goals: (i) explain
the epidemiological impact and discuss implications of overweight and
obesity. (ii) understand
theories regarding development of obesity, identify the diagnostic
criteria for overweight and obesity. (iii) assess patients risk-status and develop treatment
goals for weight loss and weight maintenance, evaluating the role of
nonpharmacological interventions, dietary supplements, and surgery. (iv) Evaluate the role of
pharmacological interventions in weight loss therapy based on
patient-specific characteristics, designing an appropriate treatment
plan and treatment–specific monitoring plan.
Lesson 4. Counseling Patients with Minor Dermatological Conditions
4 contact hours, 018-999-08-704-H01
Author: Steven Pray, Ph.D., D.Ph., Southwestern Oklahoma State
University College of Pharmacy
Educational Goals: (i) recognize dermatological conditions (ii)
identify patients with dermatological conditions amenable to
self-therapy, and those that require referral (iii) choose appropriate
nonprescription therapy for various dermatological conditions (iv)
appropriately counsel patients when recommending nonprescription
products .
|
|
Volume 33
Price - $50 per volume
Must submit for CE credit by 03/01/2010
Number 1. New Drugs: A Practical
Guide for Pharmacists
4.0
contact hours, 018-999-07-701-H01
Author: Carroll L. Ramos, R.Ph., Ph.D., Southwestern
Oklahoma State
University, Weatherford, OK
Educational Goals: (i) identify
the pharmacological and/or therapeutic classification. (ii) Describe
the approved indication. (iii) Understand the basic mechanism of
action. (iv) Describe common adverse effects. (v) Recognize clinically
relevant drug interactions. (vi) Discuss important patient information.
(vii) Recognize an appropriate dosage regimen.
Number 2. New Therapeutic
Options in the Management of Type 2 Diabetes
4.0
contact hours, 018-999-07-702-H01
Author: Betsy Carlisle, Pharm.D., CDE, Brackenridge
Hospital, Austin, TX.
Educational Goals: (i)
Identify the action patterns of the newer insulins: detemir (Levemir),
glulisine (Apidra) and inhaled insulin (Exubera) and their role in
basal-bolus insulin regimens. (ii) Understand the role of the new
incretin mimetic exenatide (Byetta) in addressing insulin resistance
and beta-cell dysfunction. (iii) Describe the potential for pramlintide
(Symlin), a synthetic amylin analogue, to complement the action of
insulin by reducing glucagon secretion, affectin satiety and slowing gastrointestinal
emptying.
Number 3. Therapeutic
Strategies for Hypertension
4.0
contact hours, 018-999-07-703-H01
Author: Alan J. Zillich, Pharm.D. Purdue
University, Indianapolis, IN
Educational Goals:
(i)Delineate the epidemiologic impact of hypertension on society. (ii)
Understand hypertension pathophysiology and related clinical sequelae.
(iii) Identify the stages of hypertension outlined by the Seventh Joint
national Committee on the Prevention, Detection, and Treatment of High
Blood Pressure (JNC-7). (iv) Compare and contrast the mechanisms of
action for antihypertensive medications. (v) Construct treatment plans
for a patient with hypertension and concomitant disease states. (vi)
Evaluate patient-specific information and scientific evidence to support
appropriate pharmacologic and non-pharmacologic therapies. (vii)
Develop specific educational messages for a patient with hypertension.
Number 4. The Metabolic
Syndrome
4.0
contact hours, 018-999-07-704-H01
Author: Joan M. Rider, B.S., Pharm.D., BCPS, CDE, FMPA, Ferris State
University, Grand Rapids, MI
Educational Goals: (i) Define
the metabolic Syndrome (MetS) and its relationship to the development
and management of cardiovascular disease and type 2 diabetes mellitus
(ii) Discuss the health factors that make up the MetS. (iii) Deliberate
the role of inflammation, thrombosis and high sensitivity-complement
reactive protein (hs-CRP) in the MetS. (iv) Determine aggressive
treatment options for the abnormal health components that lead to
Cardiometabolic Risk (CMR).
|
|
|
Volume 32
Price - $40 per volume
Must submit for CE credit by 03/01/2009
Number 1. Anxiety
Disorders
4 contact hours,
018-999-06-701-H01
Author: E. Ben Welch, III, Pharm.D., Southwestern Oklahoma State
University
Educational Goals: (i) identify which psychiatric disorders are
classified as anxiety disorders (ii) describe the signs and symptoms of
the various anxiety disorders (iii) identify which antidepressants may
be used to treat anxiety disorders (iv) formulate a rational clinical
approach for the treatment of each of these anxiety disorders. (v)
recognize patient educational considerations dealing with anxiety
disorders.
Number 2. Osteoporosis
4 contact hours,
018-999-06-702-H01
Author: Donald R. Miller, Pharm.D., North Dakota State University
Educational Goals: (i) describe normal bone physiology (ii)
contrast different methods of evaluating bone density (iii) list causes
and risk factors associated with osteoporosis (iv) suggest preventative
measures for osteoporosis (v) formulate treatment goals for
osteoporosis patients (vi) describe treatment options for osteoporosis
(vii) choose appropriate therapy for patients based on patient and drug
factors (viii) describe proactive steps that pharmacists can take to
provide pharmaceutical care for osteoporosis patients.
Number 3. Update on
Pharmacy Law
4 contact hours,
018-999-06-703-H03
Author: Alan R. Spies, R.Ph., J.D., M.B.A., Sanford University
Educational Goals: (i) describe recent changes, both actual and
proposed, to the Controlled Substances Act (ii) understand the legal
implications involved with a pharmacist’s refusal to fill a
prescription (iii) identify and rectify potential sexual harassment
violations as the relate to Title VII of the Civil Rights Act.
Number 4. Chronic Kidney
Disease
4 contact hours,
018-999-06-704-H01
Author: Cynthia A. Naughton, Pharm.D., BCPS, North Dakota State
University
Educational Goals: (i) distinguish between mild, moderate, and
severe CKD (ii) identify risk factors for CKD and explain their impact
on the development and progression of the disease (iii) recommend
interventions to control CKD progression and improve outcomes (iv)
recommend interventions to prevent and treat complications of CKD.
|
|
|
Single-Theme Courses
|
|
NONE CURRENTLY AVAILABLE
|
|
Click here for
Registration Form or Brochure
Home Study
Course Information and Frequently Asked Questions
|
|
|
